{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:54:59Z","timestamp":1761490499983,"version":"3.37.3"},"reference-count":12,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T00:00:00Z","timestamp":1519084800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transfusion"],"published-print":{"date-parts":[[2018,4]]},"abstract":"<jats:sec><jats:title>BACKGROUND<\/jats:title><jats:p>In 2016, the US Food and Drug Administration changed the regulation from a permanent deferral from donation for men who have sex with men (MSM) to a 1\u2010year deferral since last sexual contact. It is unknown what proportions of MSM try to donate and if they would be willing to answer individual risk\u2010based questions to assess their current eligibility.<\/jats:p><\/jats:sec><jats:sec><jats:title>STUDY DESIGN AND METHODS<\/jats:title><jats:p>The National HIV Behavioral Surveillance surveys periodically measure human immunodeficiency virus (HIV) prevalence and risk behaviors among MSM using a venue\u2010based, time\u2010location sampling method. In the 2014 cycle, that is, before the policy change, investigators in San Francisco and New Orleans added questions about blood donation. Questions inquired into three domains: donation history, policy awareness, and knowledge about HIV testing of donations.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS<\/jats:title><jats:p>There were 404 and 557 respondents in San Francisco and New Orleans, respectively. Nearly one in three MSM in San Francisco (27.4%) and New Orleans (31.4%) tried to donate after their first MSM contact. A majority (63.1% in San Francisco, 58.8% in New Orleans) somewhat or strongly agreed that they would be willing to be asked detailed questions for donation eligibility assessment.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS<\/jats:title><jats:p>The proportion of MSM who reported trying to donate was similar in the two cities. However, a substantial proportion did not agree to be asked more detailed risk behavior questions to assess eligibility. In these two geographic locations, prominent regional differences were not evident.<\/jats:p><\/jats:sec>","DOI":"10.1111\/trf.14522","type":"journal-article","created":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T20:08:18Z","timestamp":1519243698000},"page":"969-973","source":"Crossref","is-referenced-by-count":6,"title":["Blood donation history and eligibility assessment in a community\u2010based sample of men who have sex with men"],"prefix":"10.1111","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6251-366X","authenticated-orcid":false,"given":"Brian","family":"Custer","sequence":"first","affiliation":[{"name":"Blood Systems Research Institute"},{"name":"Department of Laboratory Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Murcia","sequence":"additional","affiliation":[{"name":"San Francisco Department of Public Health San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William T.","family":"Robinson","sequence":"additional","affiliation":[{"name":"Louisiana Department of Public Health Louisiana Office of Public Health STD\/HIV Program"},{"name":"Behavioral and Community Health Sciences, School of Public Health Louisiana State University New Orleans Louisiana."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willi","family":"McFarland","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics University of California San Francisco"},{"name":"San Francisco Department of Public Health San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry Fisher","family":"Raymond","sequence":"additional","affiliation":[{"name":"Department of Epidemiology and Biostatistics University of California San Francisco"},{"name":"San Francisco Department of Public Health San Francisco California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2018,2,20]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"Revised recommendations for reducing the risk of human immunodeficiency virus transmission by blood and blood products. Guidance for industry [Internet]. Silver Spring (MD): U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research;2015[cited 2016 Feb 23]. Available from:http:\/\/www.fda.gov\/BiologicsBloodVaccines\/GuidanceComplianceRegulatoryInformation\/Guidances\/default.htm."},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13247"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13268"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12124"},{"key":"e_1_2_7_6_1","unstructured":"National HIV Behavioral Surveillance (NHBS) [Internet]. Atlanta: Division of HIV\/AIDS Prevention National Center for HIV\/AIDS Viral Hepatitis Sexual Transmitted Diseases and Tuberculosis Prevention Centers for Disease Control and Prevention;2016[cited 2017 May 24]. Available from:https:\/\/www.cdc.gov\/hiv\/statistics\/systems\/nhbs\/."},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1177\/00333549071220S107"},{"key":"e_1_2_7_8_1","unstructured":"Metropolitan Transportation Commission and Association of Bay Area Governments. Bay area census [Internet]. San Francisco: MTC\u2010ABAG Library; [cited 2017 Jul 12]. Available from:http:\/\/www.bayareacensus.ca.gov\/bayarea.htm."},{"key":"e_1_2_7_9_1","unstructured":"US Census Bureau. Population estimates 2016 [Internet]. Washington (DC): US Department of Commerce;2010[cited 2017 Jul 12]. Available from:https:\/\/www.census.gov\/quickfacts\/LA."},{"key":"e_1_2_7_10_1","unstructured":"Blood Products Advisory Committee. December 2 2014: Blood Products Advisory Committee meeting issue summary [Internet]. Silver Spring (MD):U.S. Food and Drug Administration;2014[cited 2017 May 25]. Available fromhttps:\/\/wayback.archive-it.org\/7993\/20170113014443\/http:\/\/www.fda.gov\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/BloodProductsAdvisoryCommittee\/ucm424979.htm#E."},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.12535"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2004.04215.x"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiv500"}],"container-title":["Transfusion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Ftrf.14522","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/trf.14522","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T06:38:57Z","timestamp":1695537537000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/trf.14522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,20]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["10.1111\/trf.14522"],"URL":"https:\/\/doi.org\/10.1111\/trf.14522","archive":["Portico"],"relation":{},"ISSN":["0041-1132","1537-2995"],"issn-type":[{"type":"print","value":"0041-1132"},{"type":"electronic","value":"1537-2995"}],"subject":[],"published":{"date-parts":[[2018,2,20]]}}}